Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis
Ying Zhang, Wenlin Wu, Mengru Yang, Jie Liu, Huanmei Wu, Yaokai Chen · 2025
Read Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis by Ying Zhang, Wenlin Wu, Mengru Yang, Jie Liu, Huanmei Wu, Yaokai Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12821861.txt.
Description
BackgroundThe world’s first HIV integrase inhibitor, raltegravir (RAL), has been widely used for the treatment of HIV infection over the past 15 years, and continues benefiting people living with HIV (PLWH) today due to its efficient virological suppression and favourable safety profile.
Catalog record
| CREATOR | Ying Zhang, Wenlin Wu, Mengru Yang, Jie Liu, Huanmei Wu, Yaokai Chen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |